Health-related quality of life and incident cardiovascular disease events in community-dwelling older people: A prospective cohort study


      • Our study provides some of the first evidence that health-related quality of life (HRQoL) is associated with incident CVD.
      • Lower physical HRQoL is associated with a high CVD risk in relatively healthy older people.
      • Physical HRQoL can be used in combination with clinical information to evaluate incident CVD risk among older people.



      Lower health-related quality of life (HRQoL) has been shown to predict a higher risk of hospital readmission and mortality in patients with cardiovascular disease (CVD). Few studies have explored the associations between HRQoL and incident CVD. We explored the associations between baseline HRQoL and incident and fatal CVD in community-dwelling older people in Australia and the United States.


      Longitudinal study using ASPirin in Reducing Events in the Elderly (ASPREE) trial data. This includes 19,106 individuals aged 65–98 years, initially free of CVD, dementia, or disability, and followed between March 2010 and June 2017. The physical (PCS) and mental component scores (MCS) of HRQoL were assessed using the SF-12 questionnaire. Incident major adverse CVD events included fatal CVD (death due to atherothrombotic CVD), hospitalizations for heart failure, myocardial infarction or stroke. Analyses were performed using Cox proportional-hazard regression.


      Over a median 4.7 follow-up years, there were 922 incident CVD events, 203 fatal CVD events, 171 hospitalizations for heart failure, 355 fatal or nonfatal myocardial infarction and 403 fatal or nonfatal strokes. After adjustment for sociodemographic, health-related behaviours and clinical measures, a 10-unit higher PCS, but not MCS, was associated with a 14% lower risk of incident CVD, 28% lower risk of hospitalization for heart failure and 15% lower risk of myocardial infarction. Neither PCS nor MCS was associated with fatal CVD events or stroke.


      Physical HRQoL can be used in combination with clinical data to identify the incident CVD risk among older individuals.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • World Health Organization
        Cardiovascular Diseases 2017.
        ([cited 2020 July 7]. Available from:)
        • Murray C.J.L.
        • Vos T.
        • Lozano R.
        • et al.
        Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
        Lancet. 2012; 380: 2197-2223
        • Tarride J.-E.
        • Lim M.
        • Desmeules M.
        • et al.
        A review of the cost of cardiovascular disease.
        Can. J. Cardiol. 2009; 25: e195-e202
        • Bloom D.E.
        • Cafiero E.T.
        • Jané-Llopis E.
        • et al.
        The Global Economic Burden of Noncommunicable Diseases.
        World Economic Forum, Geneva2011
        • World Health Organization
        Aging and Health 2018.
        ([cited 2020 July 10]. Available from:)
        • Roth G.A.
        • Johnson C.
        • Abajobir A.
        • et al.
        Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015.
        J. Am. Coll. Cardiol. 2017; 70: 1-25
        • Gandek B.
        • Ware J.E.
        • Aaronson N.K.
        • et al.
        Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project.
        J. Clin. Epidemiol. 1998; 51: 1171-1178
        • Dyer M.T.
        • Goldsmith K.A.
        • Sharples L.S.
        • Buxton M.J.
        A review of health utilities using the EQ-5D in studies of cardiovascular disease.
        Health Qual. Life Outcomes. 2010; 8: 13
        • Westin L.
        • Nilstun T.
        • Carlsson R.
        • Erhardt L.
        Patients with ischemic heart disease: quality of life predicts long-term mortality.
        Scand. Cardiovasc. J. 2005; 39: 50-54
        • Rodríguez-Artalejo F.
        • Guallar-Castillón P.
        • Pascual C.R.
        • et al.
        Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure.
        Arch. Intern. Med. 2005; 165: 1274-1279
        • Higueras-Fresnillo S.
        • Cabanas-Sánchez V.
        • García-Esquinas E.
        • Rodríguez-Artalejo F.
        • Martinez-Gomez D.
        Physical activity attenuates the impact of poor physical, mental, and social health on total and cardiovascular mortality in older adults: a population-based prospective cohort study.
        Qual. Life Res. 2018; 27: 3293-3302
        • Myint P.K.
        • Luben R.N.
        • Surtees P.G.
        • et al.
        Relation between self-reported physical functional health and chronic disease mortality in men and women in the European Prospective Investigation into Cancer (EPIC–Norfolk): a prospective population study.
        Ann. Epidemiol. 2006; 16: 492-500
        • Williams E.D.
        • Rawal L.
        • Oldenburg B.F.
        • Renwick C.
        • Shaw J.E.
        • Tapp R.J.
        Risk of cardiovascular and all-cause mortality: impact of impaired health-related functioning and diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study.
        Diabetes Care. 2012; 35: 1067
        • Myint P.K.
        • Smith R.D.
        • Luben R.N.
        • et al.
        The short-form six-dimension utility index predicted mortality in the European Prospective Investigation into Cancer-Norfolk prospective population-based study.
        J. Clin. Epidemiol. 2010; 63: 192-198
        • Ul-Haq Z.
        • Mackay D.F.
        • Pell J.P.
        Association between physical and mental health-related quality of life and adverse outcomes a retrospective cohort study of 5,272 Scottish adults.
        BMC Public Health. 2014; 14: 1197
        • Myint K.P.
        • Surtees G.P.
        • Wainwright W.J.N.
        • et al.
        Physical health-related quality of life predicts stroke in the EPIC-Norfolk.
        Neurology. 2007; 69: 2243-2248
        • Muñoz M.-A.
        • Subirana I.
        • Elosua R.
        • et al.
        Utility of a short quality of life questionnaire to predict cardiovascular events.
        Int. J. Cardiol. 2011; 151: 392-394
        • Pinheiro L.
        • Reshetnyak E.
        • Sterling M.
        • Richman J.
        • Kern L.
        • Safford M.
        Using health-related quality of life to predict cardiovascular disease events.
        Qual. Life Res. 2019; 28: 1465-1475
        • Nilsson E.
        • Festin K.
        • Lowén M.
        • Kristenson M.
        SF-36 predicts 13-year CHD incidence in a middle-aged Swedish general population.
        Qual. Life Res. 2019; 29: 971-975
        • Rodgers J.L.
        • Jones J.
        • Bolleddu S.I.
        • et al.
        Cardiovascular risks associated with gender and aging.
        J. Cardiovasc. Dev. Dis. 2019; 6: 19
        • Aspree Investigator Group
        Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.
        Contemp. Clin. Trials. 2013; 36: 555-564
        • McNeil J.J.
        • Woods R.L.
        • Nelson M.R.
        • et al.
        Baseline characteristics of participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study.
        J. Gerontol. A Biol. Sci. Med. Sci. 2017; 72: 1586-1593
        • Ware Jr., J.E.
        • Kosinski M.
        • Turner-Bowker D.M.
        • Gandek B.
        User’s Manual for the SF-12v2® Health Survey (with a Supplement Documenting SF-12® Health Survey).
        QualityMetric Incorporated, Lincoln, RI2002
        • Ware Jr., J.E.
        • Kosinski M.
        • Keller S.D.
        A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity.
        Med. Care. 1996; 34: 220-233
        • McNeil J.J.
        • Wolfe R.
        • Woods R.L.
        • et al.
        Effect of aspirin on cardiovascular events and bleeding in the healthy elderly.
        N. Engl. J. Med. 2018; 379: 1509
        • McNeil J.
        • Nelson M.
        • Woods R.
        • et al.
        Effect of aspirin on all-cause mortality in the healthy elderly.
        N. Engl. J. Med. 2018; 379: 1519-1528
        • Antman E.
        • Bassand J.-P.
        • Klein W.
        • et al.
        Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction.
        J. Am. Coll. Cardiol. 2000; 36: 959-969
        • World Health Organization
        Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO task force on stroke and other cerebrovascular disorders.
        Stroke. 1989; 20: 1407-1431
        • Stocks N.
        • González-Chica D.
        • Woods R.
        • et al.
        Quality of Life for 19,114 participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study and their association with sociodemographic and modifiable lifestyle risk factors.
        Qual. Life Res. 2019; 28: 935-946
        • Australian Government National Health and Medical Research Council
        Draft Australian Guidelines to Reduce Health Risks from Drinking Alcohol.
        National Health and Medical Research Council, Canberra2019 (Available from:)
        • McNeil J.J.
        • Woods R.L.
        • Ward S.A.
        • et al.
        Cohort profile: the ASPREE longitudinal study of older persons (ALSOP).
        Int. J. Epidemiol. 2019; 48 (1048-9h)
        • Radloff L.S.
        The CES-D scale: a self-report depression scale for research in the general population.
        Appl. Psychol. Meas. 1977; 1: 385-401
        • Vlassoff C.
        Gender differences in determinants and consequences of health and illness.
        J. Health Popul. Nutr. 2007; 25: 47
        • Hawthorne G.
        • Osborne R.
        • Taylor A.
        • Sansoni J.
        The SF36 version 2: critical analyses of population weights, scoring algorithms and population norms.
        Qual. Life Res. 2007; 16: 661-673
        • Mancuso S.
        SF-12 v2 Scoring Using Australian Population Weights (Sam Mancuso in Scoring Algorithm, Self-Report Measures).
        ([cited 2020 October 5]. Available from:)
        • Brazier E.J.
        • Roberts E.J.
        The estimation of a preference-based measure of health from the SF-12.
        Med. Care. 2004; 42: 851-859
        • Lu W.-C.
        • Tzeng N.-S.
        • Kao Y.-C.
        • et al.
        Correlation between health-related quality of life in the physical domain and heart rate variability in asymptomatic adults.
        Health Qual. Life Outcomes. 2016; 14: 149
        • Hillebrand S.
        • Gast K.B.
        • de Mutsert R.
        • et al.
        Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression.
        Europace. 2013; 15: 742-749
        • Crosby R.D.
        • Kolotkin R.L.
        • Williams G.R.
        Defining clinically meaningful change in health-related quality of life.
        J. Clin. Epidemiol. 2003; 56: 395-407
        • Mottillo S.
        • Filion K.B.
        • Genest J.
        • et al.
        The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.
        J. Am. Coll. Cardiol. 2010; 56: 1113-1132
        • van Holten T.C.
        • Waanders L.F.
        • de Groot P.G.
        • et al.
        Circulating biomarkers for predicting cardiovascular disease risk: a systematic review and comprehensive overview of meta-analyses.
        PLoS One. 2013; 8e62080
        • Myers J.
        Exercise and cardiovascular health.
        Circulation. 2003; 107: e2-e5
        • Anokye N.K.
        • Trueman P.
        • Green C.
        • Pavey T.G.
        • Taylor R.S.
        Physical activity and health related quality of life.
        BMC Public Health. 2012; 12: 624
        • Mohr J.P.
        • Albers G.W.
        • Amarenco P.
        • et al.
        Etiology of stroke.
        Stroke. 1997; 28: 1501-1506
        • Kemp C.D.
        • Conte J.V.
        The pathophysiology of heart failure.
        Cardiovasc. Pathol. 2012; 21: 365-371
        • Thygesen S.K.
        • Alpert D.J.
        • White D.H.
        Universal definition of myocardial infarction.
        Circulation. 2007; 116: 2634-2653
        • Hare D.L.
        • Toukhsati S.R.
        • Johansson P.
        • Jaarsma T.
        Depression and cardiovascular disease: a clinical review.
        Eur. Heart J. 2014; 35: 1365-1372
        • Gupta R.
        • Stocks N.P.
        • Broadbent J.
        Cardiovascular risk assessment in Australian general practice.
        Aust. Fam. Physician. 2009; 38: 364-368
        • Fleishman A.J.
        • Cohen W.J.
        • Manning G.W.
        • Kosinski G.M.
        Using the SF-12 health status measure to improve predictions of medical expenditures.
        Med. Care. 2006; 44 (I-54-I-63)
        • Williams K.
        • Sansoni J.
        • Morris D.
        • Grootemaat P.
        • Thompson C.
        Patient-Reported Outcome Measures: Literature Review.
        Australian Commission on Safety and Quality in Health Care (ACSQHC), Sydney2016

      Linked Article